Royal Philips announced that the PreciseOnco research consortium coordinated by Philips has been awarded EUR 14.9 million in public funding from the Innovative Health Initiative. The funding supports a five year research program focused on improving precision in minimally invasive cancer treatments using advanced imaging robotic guidance and AI. The total program budget is EUR 23.9 million including EUR 9 million in industry contributions.
The PreciseOnco program combines spectral CT imaging AI powered software and robotic assistance to help physicians treat tumors with greater accuracy and consistency. The project includes five clinical studies across Europe to validate these technologies in real world hospital settings and assess clinical and economic impact.
Key research areas include spectral imaging to better distinguish tumors from healthy tissue robotic systems for sub millimeter instrument guidance and AI tools to enhance image quality reduce radiation and provide real time feedback during procedures. The consortium will also advance electrochemotherapy and other image guided cancer therapies.
Partners include industry companies Quantum Surgical and IGEA research organization European Institute for Biomedical Imaging Research medical society Cardiovascular and Interventional Radiological Society of Europe and leading university hospitals across Germany the Netherlands and France.
Leave a comment